2JJE image
Deposition Date 2008-04-03
Release Date 2009-06-30
Last Version Date 2025-04-09
Entry Detail
PDB ID:
2JJE
Keywords:
Title:
Crystal structure of T330S mutant of Rv3290c from M. tuberculosis
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.18
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
P 31 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:L-LYSINE EPSILON AMINOTRANSFERASE
Mutagens:YES
Chain IDs:A
Chain Length:449
Number of Molecules:1
Biological Source:MYCOBACTERIUM TUBERCULOSIS
Ligand Molecules
Primary Citation
Mutational Analysis of Mycobacterium Tuberculosis Lysine Epsilon-Aminotransferase and Inhibitor Co-Crystal Structures, Reveals Distinct Binding Modes.
Biochem.Biophys.Res.Commun. 463 154 ? (2015)
PMID: 26003725 DOI: 10.1016/J.BBRC.2015.05.055

Abstact

Lysine ɛ-aminotransferase (LAT) converts lysine to α-aminoadipate-δ-semialdehyde in a PLP-mediated reaction. We mutated active-site T330, N328 and E243, and structurally rationalized their properties. T330A and T330S mutants cannot bind PLP and are inactive. N328A although inactive, binds to PLP. E243A retains activity, but binds α-ketoglutarate in a different conformation. We had earlier identified 2-aminomethyl piperidine derivative as a LAT inhibitor. The co-crystal structure reveals that it mimics binding of C5 substrates and exhibits two binding modes. E243, that shields R422 in the apo enzyme, exhibits conformational changes to permit the binding of the inhibitor in one of the binding modes. Structure-based analysis of bound water in the active site suggests optimization strategies for synthesis of improved inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures